Canine arthritis pain management has been transformed by new treatments including monoclonal antibody therapy. These advances are dramatically improving quality of life for affected dogs.
Canine arthritis pain management has entered a genuinely exciting period of innovation. Monthly monoclonal antibody injections are transforming quality of life for dogs who did not respond adequately to traditional NSAIDs. The combination of novel pharmaceuticals with physical rehabilitation and environmental modification provides comprehensive pain management that dramatically improves welfare for an extremely common condition.